Arkolith/Insider Trading/SGMO/Form 4

Davis Gregory D

Head of Research & TechnologySANGAMO THERAPEUTICS, INC (SGMO) · full profile →Form 4 · filed Feb 26, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 25, 2026Tax withholding(F)5K$0.47$2K185K
Feb 24, 2026Tax withholding(F)832$0.47$391190K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002041855-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML